HansBiomed (Korea) Today
| 042520 Stock | KRW 7,460 80.00 1.06% |
Performance0 of 100
| Odds Of DistressLess than 9
|
HansBiomed is trading at 7460.00 as of the 28th of November 2024, a 1.06% down since the beginning of the trading day. The stock's open price was 7540.0. HansBiomed has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for HansBiomed are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. HansBiomed Corporation was founded in 1993 and is based in Seoul, South Korea. The company has 8.95 M outstanding shares. More on HansBiomed
Moving together with HansBiomed Stock
| 0.78 | 005930 | Samsung Electronics | PairCorr |
| 0.78 | 005935 | Samsung Electronics | PairCorr |
| 0.79 | 005385 | Hyundai Motor | PairCorr |
| 0.7 | 005387 | Hyundai Motor | PairCorr |
| 0.86 | 005380 | Hyundai Motor | PairCorr |
Moving against HansBiomed Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
HansBiomed Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. HansBiomed's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding HansBiomed or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Ho Hwang |
| Business Concentration | Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
HansBiomed (042520) is traded on KOSDAQ in Korea and employs 15 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 112.74 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate HansBiomed's market, we take the total number of its shares issued and multiply it by HansBiomed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. HansBiomed operates under Biotechnology sector and is part of Health Care industry. The entity has 8.95 M outstanding shares.
HansBiomed has accumulated about 7.52 B in cash with (4.27 B) of positive cash flow from operations.
Check HansBiomed Probability Of Bankruptcy
Ownership AllocationThe market capitalization of HansBiomed is W112.74 Billion. HansBiomed secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check HansBiomed Ownership Details
HansBiomed Risk Profiles
Although HansBiomed's alpha and beta are two of the key measurements used to evaluate HansBiomed's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.7 | |||
| Standard Deviation | 2.45 | |||
| Variance | 5.98 | |||
| Risk Adjusted Performance | (0.14) |
HansBiomed Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in HansBiomed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
HansBiomed Corporate Directors
Other Information on Investing in HansBiomed Stock
HansBiomed financial ratios help investors to determine whether HansBiomed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HansBiomed with respect to the benefits of owning HansBiomed security.